Skip to content
  • Sunday, 26 July 2026
  • 5:49 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment
Stem Cell & Regenerative Medicine

Discovery of Fam102a as a Dual Regulator of Bone Remodeling Offers New Horizons for Osteoporosis Treatment

Dwi Wanna Jun 20, 2026 0

A breakthrough in skeletal biology has emerged from the Institute of Science Tokyo, where researchers have identified a previously misunderstood…

Read More
Stem Cell & Regenerative Medicine

Bioengineered Bone Marrow Platform Offers New Frontier for Cancer Treatment Drug Testing and Deep Space Exploration

Dwi Wanna Jun 20, 2026 0

Researchers at the University of Pennsylvania School of Engineering and Applied Science, the Perelman School of Medicine, and the Children’s…

Read More
Stem Cell & Regenerative Medicine

Yale Researchers Uncover Molecular Mechanism Preventing Fertilization Offering New Paths for Infertility Treatment and Contraceptive Development

Dwi Wanna Jun 19, 2026 0

A multi-institutional research team, led by scientists at Yale University, has successfully decoded the molecular architecture of a biological mechanism…

Read More
Biotech & Genetic Research

Using Human Cerebral Organoids, Researchers Uncover How Ebola Virus Persists in the Brain, Offering Critical Insights for Treatment and Prevention

Jia Lissa Jun 18, 2026 0

An international collaborative research effort, spearheaded by scientists at the Bernhard Nocht Institute for Tropical Medicine (BNITM) in Hamburg, Germany,…

Read More
Neuroscience & Brain Research

ETH Zurich Researchers Identify Breakthrough Compound 10 as a Potential New Frontier in Alzheimer’s Disease Treatment and Neuroprotection

Rifan Muazin Jun 18, 2026 0

A multidisciplinary research team at ETH Zurich has announced the discovery of a novel experimental substance, currently designated as Compound…

Read More
Laboratory Automation & Robotics

Beyond PD-1: The Drugs Reshaping Cancer Treatment at ASCO 2026

Lana Keisha Jun 17, 2026 0

The biomedical sector is once again experiencing a vibrant resurgence, marked by robust investment, strategic mergers and acquisitions (M&A), and…

Read More
Stem Cell & Regenerative Medicine

Unveiling the Explosive Origins of Chronic Myeloid Leukemia: New Genomic Research Reveals Rapid Pre-Diagnostic Growth and Treatment Implications

Dwi Wanna Jun 16, 2026 0

In a landmark study that challenges long-standing assumptions about the progression of blood cancers, researchers from the Wellcome Sanger Institute…

Read More
Stem Cell & Regenerative Medicine

HKUMed Researchers Identify Piezo1 Protein as Bone Exercise Sensor Opening New Frontiers for Osteoporosis Treatment and Exercise Mimetics

Dwi Wanna Jun 14, 2026 0

In a landmark study that bridges the gap between mechanical movement and molecular biology, a research team from the LKS…

Read More
Laboratory Automation & Robotics

J&J Poster Puts Spravato Remission Data at Center of Treatment-Resistant Depression Growth Push

Lana Keisha Jun 13, 2026 0

More than six decades after Calvin Stevens first synthesized ketamine at Parke-Davis while searching for a safer anesthetic, the molecule…

Read More
Pharmaceutical R&D

Eli Lilly and Ascidian Therapeutics Forge Strategic Alliance to Revolutionize Kidney Disease Treatment Through Advanced Genetic Medicine

Teuku Ryan Jun 4, 2026 0

Eli Lilly and Company has announced a significant research collaboration and licensing agreement with Ascidian Therapeutics, a pioneering biotechnology firm…

Read More

Posts pagination

1 … 3 4 5 … 13
Excalipoint Therapeutics Launches with $68.7 Million Seed Funding to Advance Novel T-Cell Engager PipelineTop Automated Dispensing Cabinets for Pharmacies: Leading Brands ComparedScientists Uncover the Cellular Mechanism of Lecanemab in Alzheimer’s Disease and the Critical Role of the Fc Fragment in Plaque ClearanceBreakthrough in MXene Synthesis Unlocks Unprecedented Conductivity and Surface Control for Next-Generation Electronics
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ